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De Novo and Inherited Mutations in COL4A2, Encoding
the Type IV Collagen a2 Chain Cause Porencephaly
Yuriko Yoneda,1 Kazuhiro Haginoya,2,3 Hiroshi Arai,4 Shigeo Yamaoka,5 Yoshinori Tsurusaki,1
Hiroshi Doi,1 Noriko Miyake,1 Kenji Yokochi,6 Hitoshi Osaka,7 Mitsuhiro Kato,8 Naomichi Matsumoto,1
and Hirotomo Saitsu1,*
Porencephaly is a neurological disorder characterized by fluid-filled cysts or cavities in the brain that often cause hemiplegia. It has been
suggested that porencephalic cavities result from focal cerebral degeneration involving hemorrhages. De novo or inherited heterozygous
mutations in COL4A1, which encodes the type IV a1 collagen chain that is essential for structural integrity for vascular basement
membranes, have been reported in individuals with porencephaly. Most mutations occurred at conserved Gly residues in the Gly-
Xaa-Yaa repeats of the triple-helical domain, leading to alterations of the a1a1a2 heterotrimers. Here we report on two individuals
with porencephaly caused by a heterozygous missense mutation in COL4A2, which encodes the type IV a2 collagen chain. Mutations
c.3455G>A and c.3110G>A, one in each of the individuals, cause Gly residues in the Gly-Xaa-Yaa repeat to be substituted as
p.Gly1152Asp and p.Gly1037Glu, respectively, probably resulting in alterations of the a1a1a2 heterotrimers. The c.3455G>Amutation
was found in the proband’s mother, who showed very mild monoparesis of the left upper extremity, and the maternal elder uncle, who
had congenital hemiplegia. The maternal grandfather harboring the mutation is asymptomatic. The c.3110G>A mutation occurred de
novo. Our study confirmed that abnormalities of the a1a1a2 heterotrimers of type IV collagen cause porencephaly and stresses the
importance of screening for COL4A2 as well as for COL4A1.Porencephaly (MIM 175780) is a neurological disorder
characterized by fluid-filled cysts or cavities in the brain.1
It has been suggested that porencephalic cysts are caused
by a disturbance of vascular supply leading to cerebral
degeneration.2,3 Porencephaly clinically causes hemiplegia
(most often), tetraplegia, epilepsy, and intellectual
disability.4,5 Monozygous twinning, maternal cardiac
arrest or abdominal trauma, a deficient protein C anticoag-
ulant pathway, or cytomegalovirus infections are risk
factors for sporadic porencephaly.2,6 Recently, mutations
in the gene encoding type IV collagen a1 chain (COL4A1
[MIM 120130]) have been shown to cause familial poren-
cephaly.7 Since then, de novo and inherited COL4A1
mutations have been reported,8–10 confirming that
COL4A1 abnormalities are involved in both sporadic and
familial porencephaly. Type IV collagens are basement
membrane proteins that are expressed in all tissues in-
cluding the vasculature. COL4A1 (a1 chain) and COL4A2
(a2 chain) are the most abundant type IV collagens, and
form heterotrimers with 2:1 stoichiometry (a1a1a2).11 A
mouse model of the heterozygous COL4A1 mutation
(Col4a1þ/Dex40) showed cerebral hemorrhage and porence-
phaly and displayed abnormalities of vascular basement
membranes, such as uneven edges, inconsistent density,
and highly variable thickness.7 In addition, a dominant
negative effect of the Col4a1þ/Dex40 mutation was demon-
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tions of the conserved Gly residue in the Gly-Xaa-Yaa
repeat of the triple-helical domain, and they have a domi-
nant negative effect on heterotrimer formation.11,12
COL4A2 (MIM 120090), which encodes the type IV a2
collagen chain, is a possible candidate for porencephaly
because its mutations may affect the a1a1a2 heterotrimer.
Supporting this idea, osteogenesis imperfecta type I-IV
(MIM 166200, 166210, 259420, and 166220), which is
characterized by abnormal bone fragility and low bone
mass, is caused by mutations in both COL1A1 (MIM
120150) and COL1A2 (MIM 120160) that may interfere
with formation of the collagen I a1a1a2 heterotrimer.13
Moreover, mice lines harboring Col4a2 point mutations
(Col4a2ENU415, c.227G>T [p.Val31Phe]; Col4a2ENU4003
and Col4a2ENU4020, c.2073G>A [p.Gly646Asp]) showed
abnormalities of the lens, cornea, and vascular stability.14
In the brains of the mutants, pseudocysts in the upper
cortical plate, hemorrhages surrounding small blood
vessels, and focal hemorrhagic necroses were observed,
indicating that Col4a2 mutations cause abnormalities of
the cerebral vasculature similar to those caused by Col4a1
mutations.7,14 In this study, we screened for COL4A2
mutations in 35 Japanese individuals with porencephaly.
Substitutions of a Gly residue in the Gly-Xaa-Yaa repeat
were identified in two individuals (individuals 1 and 2).
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Figure 1. Pedigrees and COL4A2 Muta-
tions in Individuals 1 and 2
Pedigrees of family 1(A) and family 2 (B).
The arrows indicate the probands (Indi-
vidual 1 in family 1 and individual 2 in
family 2). The segregation of the COL4A2
mutations is shown. In family 1, the
proband’s mother (III-2) and maternal
uncle (III-1) had mild monoparesis of the
left upper extremity and congenital left
hemiplegia and an assisted walk, respec-
tively. The maternal grandfather (II-7)
was healthy. The elder granduncle (II-5)
was also afflicted by congenital hemiplegia
and died in his 60s. (B) In family 2, the
proband had a heterozygous mutation,
but his parents did not have this mutation,
indicating that the mutation occurred de
novo. His elder sister (II-2) had intraven-
tricular hemorrhage two days after birth
but her DNA was unavailable.
(C) Electropherogram of family 1 (left) and
family 2 (right). The intron and exon bases
are in lower and upper cases, respectively.
The c.3455G>A (p.Gly1152Asp) mutation
in individual 1 was inherited from his
mother. The c.3110G>A (p.Gly1037Glu)
mutation in individual 2 occurred de
novo.
(D) Multiple amino acid sequence align-
ments of COL4A2 proteins showing
the evolutionarily conserved amino acids.
The protein sequences obtained from
the National Center for Biotechnology
Information protein database are,
NP_001837.2 (Homo sapiens), NP_034062.3
(Mus musculus), NP_001155862.1
(Gallus gallus), XP_002933063.1 (Xenopus
tropicalis), XP_687811.5 (Danio rerio),
AAB64082.1 (Drosophila melanogaster), and
CAA80537.1 (Caenorhabditis elegans). The
multiple sequence alignment was per-
formed via the CLUSTALW website (see
Web Resources). The positions of the
conserved Gly residues in the Gly-X-Y
repeats where the mutations occurred are
highlighted with gray.obtained from their family members after obtaining
written informed consent. Experimental protocols were
approved by the Institutional Review Board of Yokohama
City University School of Medicine.
Individual 1 is 7 years old and a product of nonconsan-
guineous healthy parents (Figure 1A, arrow). There was no
abdominal traumatism associated with the pregnancy and
delivery in the mother. The individual was born at
36 weeks’ gestation with a planned Caesarean section
because, at 31 weeks’ gestation, an antenatal ultrasound
scan revealed an enlarged right lateral ventricle. Apgar
scores were 9 at 1 min and 10 at 5 min. He weighed
2,900 g (þ1.09 standard deviation [SD]) and had a head
circumference of 32.5 cm (þ0.05 SD). His early develop-
ment was delayed with poor left hand use and abnormal
leg movement. Brain magnetic resonance imaging (MRI)
at 6 months showed an enlarged right lateral ventricle.
Abrupt vomiting and nausea followed by motionless arrestThe Amdeveloped at the 10 months. An electroencephalogram
(EEG) showed focal spikes in the right frontal region, and
carbamazepine treatment was initiated at the 12 months.
Rehabilitation was started at 10 months. The individual
started rolling at 12 months, crawling at 18 months, and
walking alone at 3 years. He had spastic triplegia (diplegia
and left hemiplegia) showing hemiplegic and diplegic gait
with fluent speech and normal word comprehension. At
the 5 years of age, he underwent orthopedic surgery for
foot deformity due to spastic paresis. An EEG showed
spikes in the right occipital to posterior temporal region
and midcentral region. A brain MRI at age 6 showed an
enlarged right lateral ventricle, reduced volume of the right
frontal white matter, and atrophic right cerebral peduncle
and body of corpus callosum (Figures 2A–2C). His intelli-
gent quotient [IQ] score, evaluated at 6 years with Wechs-
ler Intelligence Scale for Children-Third Edition (WISC-III),
was 74 (his performance IQ was 69 and his verbal IQ waserican Journal of Human Genetics 90, 86–90, January 13, 2012 87
Figure 2. Brain Imaging in Individuals 1
and 2
(A–C) Brain MRIs of individual 1 at 6 years
old; (A) T2-weighted axial image. (B)
Coronal image. The images in (A) and (B)
show an enlarged right lateral ventricle
and a reduced volume of the right frontal
white matter. (C) T1-weighted midline
sagittal image showing atrophy of the
body of the corpus callosum (arrowheads).
The lesion responsible for the left leg
paresis is not evident in these images.
(D–F) Brain MRIs of individual 1’s mother
at age 31. (D) T2-weighted axial and (F)
coronal images show a mildly enlarged
right lateral ventricle. (E) FLAIR axial
image shows high signal intensity around
the enlarged ventricular wall, which is
consistent withmild porencephaly or peri-
ventricular venous infarction.
(G–I) CT images of individual 2 at
2 months of age. (G) Axial image. (H)
Coronal image. (I) Sagittal image. The
images in (G), (H), and (I) show an
enlarged bilateral lateral ventricle and an
extremely reduced volume of bilateral
frontal white matter. The V-P shunt tube
is also visible in the right lateral ventricle.
The pontocerebellar structures seem to be
normal.82). The individual is now 7 years old and attending a local
school. He can walk with ankle foot orthosis and hand
assist. The epilepsy is well controlled with carbamazepine
and clobazam. He does not show hematuria, muscular
cramps, or ophthalmic abnormalities. His mother was
born at term without asphyxia after an uneventful preg-
nancy. She had convulsions at the age of 18 months, and
anticonvulsant was started under a diagnosis of focal
epilepsy. Seizures were well controlled and treatment was
discontinued at the age of 13. She first realized clumsiness
of the left hand when she started learning piano and
recorder at the age of 9. When she was a junior high school
student, she felt severe headaches, and abnormal findings
were pointed out in the brain MRI study (detailed informa-
tion was unavailable). However, she did not undergo any
more examinations because the headaches disappeared
and did not recur. Neurological examination at 31 years re-
vealed very mild monoparesis of the left upper extremity.
She had neither spasticity nor exaggerated tendon reflexes.
The grip power of her right and left hands was 25 and
15 kg, respectively. Mirror movement was observed on
the right hand. The brain MRI revealed a mildly enlarged
right lateral ventricle and high signal intensity around
the enlarged ventricular wall on a Fluid Attenuated Inver-
sion Recovery (FLAIR) image, which is consistent with
mild porencephaly or periventricular venous infarction
(Figures 2D–2F). MR angiography showed no aneurysms.
Of note, his maternal elder uncle also showed congenital88 The American Journal of Human Genetics 90, 86–90, January 13, 2left hemiplegia with an assisted walk, and his maternal
granduncle had also been afflicted by congenital hemi-
plegia, suggesting a genetic predisposition in the family
(Figure 1A).
Individual 2 is 1 year and 4 months old and a product
of nonconsanguineous healthy parents (Figure 1B, arrow).
There was no abdominal traumatism associated with the
pregnancy and delivery in the mother. He was born at
35weeks’ gestation.His birthweightwas 1,694g (2.36 SD)
and his head circumference was 29 cm (1.77 SD). Mild
asphyxia was observed, and he had Apgar scores of 3 at
1 min and 7 at 5 min. An ultrasound scan at 6 hr after birth
revealed a parenchymal hemorrhage of the right cerebral
hemisphere with an enlarged left lateral ventricle. Because
a blood test revealed significant increases in prothrombin
time (29.3 s) and activated partial thromboplastin time
(104.3 s), but not inD-dimer (0.7 mg/ml) at 1 day after birth,
he was treated with a daily infusion of fresh frozen plasma
for 12 days. At 37 days after birth, he underwent a ventric-
ular-peritoneal shunt (V-P shunt) operation for progressive
enlargement of the lateral ventricle. Computed tomog-
raphy (CT) at 2 months of age showed an enlarged bilateral
lateral ventricle and an extremely reduced volume of
bilateral frontal white matter (Figures 2G–2I). Blood coagu-
lation was normalized at 7 months. At the 7 months, the
individual did not show any head control or rolling, and
presented with abnormal posturing and spastic quadri-
plegia dominant on the left side of his body. With012
rehabilitation, he had full-range visual pursuit, a social
smile, and incompletehead control. Althoughhis spasticity
improved, exaggerated deep tendon reflexes with synergic
voluntary movement of the distal part of the extremities
were recognized. An EEG at 1 year of age showed no
epileptic discharges. His present developmental quotient
is below 20. He did not show hematuria, muscular cramps,
intracranial aneurysms, or cataracts. His elder sister was
found to have an intraventricular hemorrhage two days
after birth and underwent a V-P shunt. Her development
was almost normal, and internal strabismus was noted.
Unfortunately, she died in an accident at the age of four,
and so her DNA was unavailable (Figure 1B).
Genomic DNAwas isolated from peripheral blood leuko-
cytes according to standard methods. DNA for mutation
screening was amplified by illustra GenomiPhi V2 DNA
Amplification Kit (GE Healthcare, Buckinghamshire, UK).
The DNA of family members of individual 1 was isolated
from saliva samples with Oragene (DNA Genotek Inc.,
Ontario, Canada). Exons 2 to 48 covering the entire
COL4A2 coding region (GenBank accession number
NM_001846.2) were examined by high-resolution melting
curve (HRM) analysis or directly sequenced (for exon 46).
The samples showing an aberrant melting curve pattern
in the HRM analysis were sequenced. PCR primers and
conditions are shown in Table S1, available online. All the
mutations were verified with genomic DNA as a template.
Two heterozygous mutations, c.3455G>A (p.Gly1152Asp)
in individual 1 and c.3110G>A (p.Gly1037Glu) in indi-
vidual 2, were identified. Both mutations occur at evolu-
tionary conserved Gly residues in the Gly-X-Y repeats
(Figure 1D), suggesting that the two mutations may alter
the collagen IV a1a1a2 heterotrimers. These mutations
were absent in 200 normal Japanese controls, and our
evaluation with web-based prediction tools strongly sug-
gested that these substitutions are pathogenic (Table S2).
Screening for COL4A1 mutations was negative for both
individuals (data not shown). The c.3455G>A mutation
was found in the proband’smother and thematernal uncle,
who showed very mild monoparesis of the left upper
extremity and congenital left hemiplegia, respectively,
and in maternal grandfather who is asymptomatic (Figures
1A and 1B). Therefore the c.3455G>A mutation can be
considered as a pathogenic mutation with incomplete
penetrance. The c.3110G>A mutation in individual 2 was
not found in his parents, indicating that this mutation
occurred de novo (Figure 1C).
Here we report two individuals with porencephaly who
harbor COL4A2 mutations. In individual 2, the mutation
occurred de novo. It is noteworthy that individual 2’s elder
sister also suffered from an intraventricular hemorrhage. A
coincidental phenocopy in the sister is possible and would
be consistent with de novo occurrence of the mutation.
Alternatively, the sister might have the same mutation,
which could be inherited from either one of the parents
with a germline-mosaicmutation, though itwas impossible
to examine the sister because her sample is unavailable.The AmThus, with the present data, we concluded that the
c.3110G>A mutation occurred de novo. On the other
hand, the mutation in individual 1 was inherited from his
mildly affected mother. In addition, congenital hemiplegia
is observed in familialmembers of individual 1; the segrega-
tion of the c.3455G>Amutation is consistent with a domi-
nant trait with incomplete penetrance. Such incomplete
penetrance also has been reported in familial porencepha-
lies with COL4A1mutations,8,9 suggesting that abnormali-
ties of collagen IV a1a1a2 heterotrimers may conspire with
other risk factors. The porencephalic cyst was unilateral in
individual 1 and bilateral in individual 2, who required
shunting, indicating variable severities caused by the
different COL4A2 mutations. Most porencephalic cysts
caused by COL4A1 mutations are unilateral;9 however,
Meuwissen et al. recently reported de novo COL4A1 muta-
tions in sporadic extensive bilateral porencephaly re-
sembling hydranencephaly, indicating similar variable
severities caused by COL4A1 mutations.10 Thus the
involvement ofCOL4A1 andCOL4A2 abnormalities should
be considered in porencephaly and related pre- and peri-
natal cerebral hemorrhages, regardless of their severities.
It has been reported that COL4A1 mutations cause
a variety of phenotypes, including porencephaly, infantile
hemiplegia, and cerebral small vessel diseases involving
both ischemic stroke and intracerebral hemorrhage with
radiological features of lacunar infarction, and leukoaraio-
sis in adult individuals.9,15–18 The phenotypes in the
central nervous system are often accompanied by ocular
features (cataracts, retinal vessel tortuosity and hemor-
rhage, and defects of the anterior segment of the eye),
nephropathy, and muscle cramps.9,16,17 Considering the
common pathological mechanism between COL4A1 and
COL4A2 mutations (abnormalities of collagen IV a1a1a2
heterotrimers), COL4A2 mutations also may be involved
in small vessel diseases that can be manifested in adult-
hood. Supporting this idea, mice lines harboring Col4A2
point mutations showed cataracts, abnormalities of the
lens and the cornea, and cerebral abnormalities.14 Thus it
is important to identify mutations in both COL4A1 and
COL4A2 in individuals with porencephaly as well as in
asymptomatic carriers, for whom the prevention of stroke
and genetic counseling are quite important. Identification
of pathogenic mutations in individuals with porencephaly
is of great interest for obstetricians and pediatricians, and
for neurologists working for adult individuals.
In summary, we have identified mutations in COL4A2 as
a genetic cause of both sporadic and familial porencephaly.
Our data further support the importance of genetic testing
in porencephaly and related pre- and perinatal cerebral
hemorrhages for which the genetic predisposition is grad-
ually being uncovered.Supplemental Data
Supplemental Data include two tables and can be found with this
article online at http://www.cell.com/AJHG/.erican Journal of Human Genetics 90, 86–90, January 13, 2012 89
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